NuCapCure Project Launches to Develop Tailored Multimodal Treatments for GBM Brain Cancer.
NuCap Cure

On the 29th of February 2024, the newly launched research project NuCapCure officially kicked off its activities in Oslo, Norway. The project consortium, led by coordinator Dr Theodossis Theodossiou from the University of Oslo, comprises seven European institutions, including the UMCG.

The activity at UMCG will encompass the development of irradiation modalities at the pre-clinical research centre PARTREC. The work at UMCG is led by Prof. Alexander Gerbershagen (physics) and Dr. Lara Barazzuol (radiobiology).

More information can be found at:

NuCapCure Project Launches to Develop Tailored Multimodal Treatments for GBM Brain Cancer